Your News

Your News

"Your News" is a collection of news stories, articles and blog posts submitted to the Shore News Network from the general public, local businesses, community organizations and pretty much the entire world. At Shore News Network, everyone can be a journalist and report news. To do so, send your news to news@shorenewsnetwork.com. The opinions expressed in this column are those of the author and do not represent the position or opinions of Shore News Network.

GOP Leadership on the “Island” of New Jersey

Incompetence or Deliberate? Op-Ed by Rob Kovic, Esq. In a new low on the competence scale, the New Jersey GOP just lost the right to send 37 delegates to the 2024 Republican National Convention in Milwaukee, Wisconsin. NJ was supposed to send…

INNOVATIVE INDUSTRIAL PROPERTIES, INC. (NYSE: IIPR) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Innovative Industrial Properties, Inc. (NYSE: IIPR)

Did you lose money on investments in Innovative Industrial Properties? If so, please visit Innovative Industrial Properties, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or The Daily Caller News Foundation to discuss…

Jubilant Therapeutics Inc. verabreicht beim ersten Patienten die Dosis für die Phase I/II-Studie zur Untersuchung von JBI-802, einem dualen Inhibitor von LSD1 und HDAC6, bei Patienten mit fortgeschrittenen soliden Tumoren USA – English Deutschland – Deutsch

JBI-802 ist der erste oral verabreichte, duale äquipotente Hemmstoff von LSD1 und HDAC6 JBI-802 zeigte synergistische Anti-Tumor-Aktivität in Tiermodellen BEDMINSTER, N.J., 27. April 2022 — Jubilant Therapeutics Inc., ein biopharmazeutisches Unternehmen, das…
1 53 54 55 56 57 172

Facebook